InvestorsHub Logo
Followers 66
Posts 12723
Boards Moderated 0
Alias Born 06/03/2015

Re: RecklessSpeculator post# 57758

Tuesday, 03/29/2016 5:27:54 PM

Tuesday, March 29, 2016 5:27:54 PM

Post# of 462187
If the final rejection states that the combination of 2-73 and donepezil is "obvious" by one knowledgeable in the art (as stated in the non-final rejection) then that means no other AD drug can be patented with donepezil, either.

It's also a moot point, since the company has determined that the results are the same with or without donepezil.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News